If Imbruvica (Ibrutinib) Isn't Approved by UnitedHealthcare in Virginia: Formulary Alternatives & Exception Paths
Answer Box: When UnitedHealthcare Denies Imbruvica in Virginia
If UnitedHealthcare denies Imbruvica (ibrutinib) for CLL/SLL in Virginia, you have two main paths: try formulary-preferred alternatives like acalabrutinib (Calquence) or zanubrutinib (Brukinsa), or request an exception with documented medical necessity. UnitedHealthcare typically requires step therapy with preferred BTK inhibitors first.